Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Therapeutics, Inc."
Count: 2306
Selected: 0
| NCT ID | Title |
|---|
| NCT04221230 | Study in Major Depressive Disorder With BTRX-335140 (NMRA-335140) vs Placebo | ||
| NCT00429936 | Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration | ||
| NCT05363449 | Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis | ||
| NCT03897257 | A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis | ||
| NCT04080206 | A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis | ||
| NCT04243486 | A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis | ||
| NCT03759197 | A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis | ||
| NCT03731052 | Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307) | ||
| NCT05294328 | Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia | ||
| NCT03307577 | A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris | ||
| NCT02368210 | A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306) | ||
| NCT02742441 | A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310) | ||
| NCT02367911 | A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis | ||
| NCT01700985 | A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis | ||
| NCT01698333 | Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression | ||
| NCT03065556 | A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203) | ||
| NCT04233814 | Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects | ||
| NCT03976401 | A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) | ||
| NCT05039450 | A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry) | ||
| NCT05268198 | SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects | ||
| NCT04740476 | An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome | ||
| NCT04442295 | An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome | ||
| NCT04767529 | A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) | ||
| NCT04847440 | A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection | ||
| NCT03315182 | Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB | ||
| NCT04159831 | A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions | ||
| NCT04485013 | TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers | ||
| NCT04088734 | Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease | ||
| NCT04227106 | Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) | ||
| NCT04205227 | ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors | ||
| NCT05298332 | Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects | ||
| NCT05238844 | A Study of Safety and Efficacy of ATI-2173 and Vebicorvir in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection | ||
| NCT02716246 | Phase I/II Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH | ||
| NCT05137600 | A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects | ||
| NCT05137548 | A Drug-Drug Interaction Study Between ATI-2173 and Tenofovir Disoproxil Fumarate in Healthy Subjects | ||
| NCT03201562 | A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia | ||
| NCT04360265 | A Long-term Follow-up Study of Patients With MPS IIIA Treated With ABO-102 | ||
| NCT04677829 | Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI) | ||
| NCT01882647 | A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305) | ||
| NCT05280067 | ZetaFuse™ Bone Graft in the Repair of Bone Defects From Metastatic Breast Cancer in the Spinal Vertebral Body | ||
| NCT04665206 | Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors Enriched for Tumors With NF2 Gene Mutations | ||
| NCT04645797 | A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions | ||
| NCT04248426 | A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection | ||
| NCT03993106 | A Study of sEphB4-HSA in Kaposi Sarcoma | ||
| NCT04486781 | A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma | ||
| NCT02657005 | TK216 in Patients With Relapsed or Refractory Ewing Sarcoma | ||
| NCT03088878 | A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies | ||
| NCT04886622 | A Study of DT2216 in Relapsed/Refractory Malignancies | ||
| NCT05251714 | CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer | ||
| NCT01166646 | Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis |
